- AAIC 2026 · LONDON · JULY 12–15
Ultrasensitive AD Biomarker Quantification
Now Within Reach.
Unlock ultrasensitive neurodegenerative biomarker quantification with Taudia’s new SPLASH™ Duplex eMTBR-Tau243 / BD pTau217 assay or
5-plex pTau217 / Aβ42 / Aβ40 / NfL / GFAP panel — all with a simple workflow and minimal or no new CapEx.
Alzheimer’s Association International Conference
- JULY 12–15
- ExCeL London, Royal Victoria Dock, UK
Find Us at BOOTH
#1209
Who We Are
Built on Vision, Driven by Precision
Taudia was founded with a shared mission: to accelerate the understanding, detection, and treatment of neurodegenerative diseases.
We develop ultrasensitive biomarker detection technology that makes advanced protein quantification simple, reliable, and accessible. Our SPLASH™ platform empowers researchers, biopharma teams, and clinicians to detect neurodegenerative biomarkers through blood-based testing — without the need for specialized instruments.
- Accessible Science
- Precision Proteomics
- Neurodegeneration Focus
Purpose-built to help uncover the unknown about Alzheimer’s, Parkinson’s, and beyond
Launching at AAIC 2026
New SPLASH™ Kits & Capabilities
Expanding the boundaries of blood-based biomarker detection with new targets, multiplexing, and sample workflows.
eMTBR-Tau243 Ultrasensitive Assay
Be among the first to access our new SPLASH-based eMTBR-Tau243 assay — a next-generation biomarker for tau pathology detection with ultrasensitive quantification from plasma.
Complete AD Biomarker Panel
Simultaneously quantify five AD biomarkers from a single plasma sample — maximizing clinical insight while minimizing sample volume.
SPLASH Kit: Brain Derived pTau-217
Ultrasensitive detection of brain-derived phosphorylated tau 217 — offering enhanced specificity for Alzheimer’s disease pathology assessment from plasma.
Dried Plasma Spot (DPS)
A novel sample collection and detection workflow enabling AD biomarker quantification from dried plasma spots — expanding access to remote and decentralized settings.
SPLASH™ Technology
Precision Proteomics, Democratized
Ultrasensitive protein quantification made simple, reliable, and affordable — on any standard qPCR instrument.
fg/mL
Detection Sensitivity
80–120%
Spike & Recovery
1 Wash
Simplified Workflow
qPCR
Standard Equipment
Assay Portfolio
SPLASH™ Kits
From singleplex to multiplex, our growing portfolio covers the key blood-based biomarkers for Alzheimer’s and neurodegeneration research.
Singleplex
pTau-217
Singleplex
Aβ42
Amyloid beta 42 quantification for amyloid pathology assessment.
Singleplex
Aβ40
Amyloid beta 40 for ratio-based amyloid status determination.
Singleplex
NfL
Neurofilament light chain — a broad neurodegeneration marker.
Singleplex
GFAP
Glial fibrillary acidic protein for astrocyte activation and neuroinflammation.
Duplex
pTau-217 + Aβ42
Two core AD biomarkers from a single well.
Duplex
Aβ40 + Aβ42
Amyloid ratio panel in a single-well format.
Duplex
NfL + GFAP
Neurodegeneration and neuroinflammation panel.
Scientific Resources
Whitepapers, App Notes & Webinars
Explore the science behind SPLASH technology and its applications in Alzheimer’s biomarker research.
White Paper
Blood-Based Biomarkers for Alzheimer’s: Impact on Clinical Trial Screening
Explores how SPLASH enables fast, accessible, ultrasensitive blood-based biomarker testing to accelerate clinical trial enrollment.
App Note
5-Plex Biomarker Profiling from a Single Plasma Sample
Simultaneous quantitation of pTau-217, Aβ42, Aβ40, NfL, and GFAP demonstrating multiplex performance and concordance.
App Note
Dried Plasma Spot Workflow for AD Biomarker Quantification
A novel DPS-based workflow enabling decentralized sample collection and ultrasensitive AD biomarker detection.
App Note
Single-Well Multiplexing: Duplex Biomarker Quantitation
Demonstrates the SPLASH platform’s ability to quantify two biomarkers simultaneously in a single well with no cross-reactivity.
Webinar
Redefining Alzheimer’s Biomarker Detection with NeuXplore
On-demand webinar covering the NeuXplore automated platform and its impact on clinical and research workflows.
Webinar
Dried Plasma Spot Testing for Alzheimer’s Detection
Learn how DPS technology is expanding access to AD biomarker testing in remote and resource-limited settings.
Booth #1209 Experience
More Than Science — Come for the Fun Too!
We’ve got exciting activities planned at our booth. Stop by, learn about SPLASH technology, and walk away with great prizes.
📚 Grab Your Printed Resources
Stop by Booth #1209 to pick up printed copies of our latest product flyers, application notes, and whitepapers — including our complete SPLASH assay portfolio, 5-plex biomarker profiling data, and dried plasma spot workflow guide. Take them home for your team!
🎫 AAIC Passport Program
Taudia is proudly enrolled in the AAIC Passport Program! Pick up your passport at the conference and make sure to visit Booth #1209 to collect your stamp.
- Pick up your AAIC Passport at registration
- Visit Booth #1209 to get your Taudia stamp
- Complete your passport to win prizes!
🎲 Booth Games & Prizes
Join us at the Taudia booth for fun interactive games and challenges! Test your biomarker knowledge, spin the prize wheel, and compete for exclusive gadgets and giveaways.
- Exclusive gadgets & tech accessories
- Adorable Taudia plushy octopus
- Surprise giveaways & swag bags
Meet Our Taudia Plushy Octopus! The cutest booth companion at AAIC — play a game at our stand for your chance to take one home. Limited quantities available!
Meet Us at AAIC 2026
Schedule a personalized meeting at Booth #1209 and see how SPLASH technology can accelerate your Alzheimer’s research.